Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
- PMID: 31906479
- PMCID: PMC7016883
- DOI: 10.3390/cells9010110
Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
Abstract
Infiltration of the lamina propria by inflammatory CD4+ T-cell populations is a key characteristic of chronic intestinal inflammation. Memory-phenotype CD4+ T-cell frequencies are increased in inflamed intestinal tissue of IBD patients compared to tissue of healthy controls and are associated with disease flares and a more complicated disease course. Therefore, a tightly controlled balance between regulatory and inflammatory CD4+ T-cell populations is crucial to prevent uncontrolled CD4+ T-cell responses and subsequent intestinal tissue damage. While at steady state, T-cells display mainly a regulatory phenotype, increased in Th1, Th2, Th9, Th17, and Th17.1 responses, and reduced Treg and Tr1 responses have all been suggested to play a role in IBD pathophysiology. However, it is highly unlikely that all these responses are altered in each individual patient. With the rapidly expanding plethora of therapeutic options to inhibit inflammatory T-cell responses and stimulate regulatory T-cell responses, a crucial need is emerging for a robust set of immunological assays to predict and monitor therapeutic success at an individual level. Consequently, it is crucial to differentiate dominant inflammatory and regulatory CD4+ T helper responses in patients and relate these to disease course and therapy response. In this review, we provide an overview of how intestinal CD4+ T-cell responses arise, discuss the main phenotypes of CD4+ T helper responses, and review how they are implicated in IBD.
Keywords: CD4+ T-cell; IBD; T helper cell; intestine.
Conflict of interest statement
The authors have no conflicts of interest.
Figures


Similar articles
-
Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.Inflamm Bowel Dis. 2014 Dec;20(12):2321-9. doi: 10.1097/MIB.0000000000000210. Inflamm Bowel Dis. 2014. PMID: 25248005
-
IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.Inflamm Bowel Dis. 2013 Mar-Apr;19(4):720-8. doi: 10.1097/MIB.0b013e3182802a76. Inflamm Bowel Dis. 2013. PMID: 23429464
-
Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.J Crohns Colitis. 2019 Mar 30;13(4):510-524. doi: 10.1093/ecco-jcc/jjy179. J Crohns Colitis. 2019. PMID: 30395204
-
CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease.Int J Mol Sci. 2023 Jan 31;24(3):2696. doi: 10.3390/ijms24032696. Int J Mol Sci. 2023. PMID: 36769019 Free PMC article. Review.
-
A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.Front Immunol. 2018 May 24;9:1139. doi: 10.3389/fimmu.2018.01139. eCollection 2018. Front Immunol. 2018. PMID: 29881387 Free PMC article. Review.
Cited by
-
Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing.Pharmaceuticals (Basel). 2022 Aug 30;15(9):1080. doi: 10.3390/ph15091080. Pharmaceuticals (Basel). 2022. PMID: 36145301 Free PMC article. Review.
-
Type 2 immunity in intestinal homeostasis and inflammatory bowel disease.Biochem Soc Trans. 2021 Nov 1;49(5):2371-2380. doi: 10.1042/BST20210535. Biochem Soc Trans. 2021. PMID: 34581755 Free PMC article. Review.
-
Intracellular hydrogelation of macrophage conjugated probiotics for hitchhiking delivery and combined treatment of colitis.Mater Today Bio. 2023 May 19;20:100679. doi: 10.1016/j.mtbio.2023.100679. eCollection 2023 Jun. Mater Today Bio. 2023. PMID: 37273799 Free PMC article.
-
Schistosoma japonicum peptide SJMHE1 inhibits acute and chronic colitis induced by dextran sulfate sodium in mice.Parasit Vectors. 2021 Sep 6;14(1):455. doi: 10.1186/s13071-021-04977-y. Parasit Vectors. 2021. PMID: 34488863 Free PMC article.
-
Investigating shared genetic architecture between inflammatory bowel diseases and primary biliary cholangitis.JHEP Rep. 2024 Feb 12;6(6):101037. doi: 10.1016/j.jhepr.2024.101037. eCollection 2024 Jun. JHEP Rep. 2024. PMID: 38721342 Free PMC article.
References
-
- Levine A., Griffiths A., Markowitz J., Wilson D.C., Turner D., Russell R.K., Fell J., Ruemmele F.M., Walters T., Sherlock M., et al. Pediatric Modification of the Montreal Classification for Inflammatory Bowel Disease: The Paris Classification. Inflamm. Bowel Dis. 2011;17:1314–1321. doi: 10.1002/ibd.21493. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials